161 related articles for article (PubMed ID: 30896620)
1. Association between KRAS G13D mutations and anastomotic recurrence in colorectal cancer: Two case reports.
Okada S; Hata K; Kawai K; Yamamoto Y; Tanaka T; Nishikawa T; Sasaki K; Kaneko M; Emoto S; Murono K; Nozawa H
Medicine (Baltimore); 2019 Mar; 98(12):e14781. PubMed ID: 30896620
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.
Tsilimigras DI; Ntanasis-Stathopoulos I; Bagante F; Moris D; Cloyd J; Spartalis E; Pawlik TM
Surg Oncol; 2018 Jun; 27(2):280-288. PubMed ID: 29937183
[TBL] [Abstract][Full Text] [Related]
3. Microsatellite instability-low colorectal cancer acquires a KRAS mutation during the progression from Dukes' A to Dukes' B.
Asaka S; Arai Y; Nishimura Y; Yamaguchi K; Ishikubo T; Yatsuoka T; Tanaka Y; Akagi K
Carcinogenesis; 2009 Mar; 30(3):494-9. PubMed ID: 19147861
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and coexistence of KRAS, BRAF, PIK3CA, NRAS, TP53, and APC mutations in Indian colorectal cancer patients: Next-generation sequencing-based cohort study.
Jauhri M; Bhatnagar A; Gupta S; Bp M; Minhas S; Shokeen Y; Aggarwal S
Tumour Biol; 2017 Feb; 39(2):1010428317692265. PubMed ID: 28222664
[TBL] [Abstract][Full Text] [Related]
5. DNA alterations of microsatellite DNA, p53, APC and K-ras in Chinese colorectal cancer patients.
Xu XM; Qian JC; Cai Z; Tang T; Wang P; Zhang KH; Deng ZL; Cai JP
Eur J Clin Invest; 2012 Jul; 42(7):751-9. PubMed ID: 22324744
[TBL] [Abstract][Full Text] [Related]
6. Combined analysis of specific KRAS mutation, BRAF and microsatellite instability identifies prognostic subgroups of sporadic and hereditary colorectal cancer.
Zlobec I; Kovac M; Erzberger P; Molinari F; Bihl MP; Rufle A; Foerster A; Frattini M; Terracciano L; Heinimann K; Lugli A
Int J Cancer; 2010 Dec; 127(11):2569-75. PubMed ID: 20162668
[TBL] [Abstract][Full Text] [Related]
7. Copy number of the Adenomatous Polyposis Coli gene is not always neutral in sporadic colorectal cancers with loss of heterozygosity for the gene.
Zauber P; Marotta S; Sabbath-Solitare M
BMC Cancer; 2016 Mar; 16():213. PubMed ID: 26970738
[TBL] [Abstract][Full Text] [Related]
8. High concordance rate of KRAS/BRAF mutations and MSI-H between primary colorectal cancer and corresponding metastases.
Fujiyoshi K; Yamamoto G; Takahashi A; Arai Y; Yamada M; Kakuta M; Yamaguchi K; Akagi Y; Nishimura Y; Sakamoto H; Akagi K
Oncol Rep; 2017 Feb; 37(2):785-792. PubMed ID: 28000889
[TBL] [Abstract][Full Text] [Related]
9. Use of multivariate analysis to suggest a new molecular classification of colorectal cancer.
Domingo E; Ramamoorthy R; Oukrif D; Rosmarin D; Presz M; Wang H; Pulker H; Lockstone H; Hveem T; Cranston T; Danielsen H; Novelli M; Davidson B; Xu ZZ; Molloy P; Johnstone E; Holmes C; Midgley R; Kerr D; Sieber O; Tomlinson I
J Pathol; 2013 Feb; 229(3):441-8. PubMed ID: 23165447
[TBL] [Abstract][Full Text] [Related]
10. Local recurrences at the anastomotic area are clonally related to the primary tumor in sporadic colorectal carcinoma.
Vakiani E; Shah RH; Berger MF; Makohon-Moore AP; Reiter JG; Ostrovnaya I; Attiyeh MA; Cercek A; Shia J; Iacobuzio-Donahue CA; Solit DB; Weiser MR
Oncotarget; 2017 Jun; 8(26):42487-42494. PubMed ID: 28476018
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of BRAF and KRAS Mutation in Relation to Colorectal Cancer Survival in Iranian Patients: Correlated to Microsatellite Instability.
Nazemalhosseini-Mojarad E; Kishani Farahani R; Mehrizi M; Baghaei K; Yaghoob Taleghani M; Golmohammadi M; Peyravian N; Ashtari S; Pourhoseingholi MA; Asadzadeh Aghdaei H; Zali MR
J Gastrointest Cancer; 2020 Mar; 51(1):53-62. PubMed ID: 30635874
[TBL] [Abstract][Full Text] [Related]
12. Genetic heterogeneity in synchronous colorectal cancers impacts genotyping approaches and therapeutic strategies.
Jesinghaus M; Pfarr N; Kloor M; Endris V; Tavernar L; Muckenhuber A; von Knebel Doeberitz M; Penzel R; Weichert W; Stenzinger A
Genes Chromosomes Cancer; 2016 Mar; 55(3):268-77. PubMed ID: 26650777
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility of KRAS and BRAF mutations in a cohort of patients with colorectal neoplasms submitted for microsatellite instability testing.
Cushman-Vokoun AM; Stover DG; Zhao Z; Koehler EA; Berlin JD; Vnencak-Jones CL
Clin Colorectal Cancer; 2013 Sep; 12(3):168-78. PubMed ID: 23773459
[TBL] [Abstract][Full Text] [Related]
14. Genomic Profiling of Stage II Colorectal Cancer Identifies Candidate Genes Associated with Recurrence-Free Survival, Tumor Location, and Differentiation Grade.
Dimberg J; Andersson RE; Haglund S
Oncology; 2020; 98(8):575-582. PubMed ID: 32408300
[TBL] [Abstract][Full Text] [Related]
15. BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis?
Velho S; Moutinho C; Cirnes L; Albuquerque C; Hamelin R; Schmitt F; Carneiro F; Oliveira C; Seruca R
BMC Cancer; 2008 Sep; 8():255. PubMed ID: 18782444
[TBL] [Abstract][Full Text] [Related]
16. Genetic Characteristics of Resectable Colorectal Cancer with Pulmonary Metastasis.
Qiu YY; Peng D; Wei ZQ; Li JD; Huang YJ; Yang JG; Song ZY; Cheng Y
Can J Gastroenterol Hepatol; 2022; 2022():2033876. PubMed ID: 35531124
[TBL] [Abstract][Full Text] [Related]
17. The interplay of KRAS mutational status with tumor laterality in non-metastatic colorectal cancer: An international, multi-institutional study in patients with known KRAS, BRAF, and MSI status.
Kamphues C; Kadowaki S; Amini N; van den Berg I; Wang J; Andreatos N; Sakamoto Y; Ogura T; Kakuta M; Pikouli A; Geka D; Daitoku N; Theochari M; Buettner S; Akiyama T; Antoniou E; Pikoulis E; Theodoropoulos G; Imai K; Ijzermans JNM; Margonis GA; Akagi K; Kreis ME
J Surg Oncol; 2021 Mar; 123(4):1005-1014. PubMed ID: 33368279
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer.
Taieb J; Le Malicot K; Shi Q; Penault-Llorca F; Bouché O; Tabernero J; Mini E; Goldberg RM; Folprecht G; Luc Van Laethem J; Sargent DJ; Alberts SR; Emile JF; Laurent Puig P; Sinicrope FA
J Natl Cancer Inst; 2017 May; 109(5):. PubMed ID: 28040692
[TBL] [Abstract][Full Text] [Related]
19. Mutational profiling of colorectal cancers with microsatellite instability.
Lin EI; Tseng LH; Gocke CD; Reil S; Le DT; Azad NS; Eshleman JR
Oncotarget; 2015 Dec; 6(39):42334-44. PubMed ID: 26517354
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of the
Matsunaga K; Sasaki K; Hata K; Nozawa H; Kawai K; Murono K; Emoto S; Yokoyama Y; Sonoda H; Ueda K; Kuriyama S; Yamada T; Yoshida H; Ishihara S
Oncol Lett; 2023 May; 25(5):192. PubMed ID: 37113399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
